Rankings
▼
Calendar
ARVN Q3 2017 Earnings — Arvinas, Inc. Revenue & Financial Results | Market Cap Arena
ARVN
Arvinas, Inc.
$856M
Q3 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
Gross Profit
$2M
100.0% margin
Operating Income
-$6M
-384.2% margin
Net Income
-$6M
-383.3% margin
EPS (Diluted)
$-0.31
QoQ Revenue Growth
+0.0%
Cash Flow
Operating Cash Flow
-$7M
Free Cash Flow
-$7M
Stock-Based Comp.
$79,660
← FY 2017
All Quarters
Q4 2017 →